Primary cultures, enriched in neurones or astroglial cells, from three phylogenetically different regions of the brain of the rat, the cerebral cortex, the striatum and the brain stem, were used to investigate the presence of opiate receptors, coupled to adenylate cyclase. Morphine was used as a mu-receptor agonist and [D-Ala2, D-Leu5]-enkephalin (DADLE) was used as a delta-receptor agonist. In the neuronal cultures, both ligands inhibited the prostaglandin (PG)E1-stimulated intracellular accumulation of cyclic AMP dose-dependently, with the most prominent effects seen in the cultures of striatum and with DADLE being more potent than morphine. The opiate receptor antagonist, naloxone reversed the effects. Morphine and DADLE, added together, inhibited the PGE1-stimulated accumulation of cyclic AMP, less than the sum of the effects of each drug. Therefore, it might be that these opioid receptors are localized together on the same neurone. Striatal neurones contained dopamine receptors coupled to cyclic AMP, as second messenger. It was shown that the D1 (dopamine) receptor-stimulated activity of adenylate cyclase was inhibited by the mu and delta-opioid receptor ligands. Thus, interactions at the level of adenylate cyclase seem to exist between D1, mu and delta-opiate receptors. In the astroglial enriched cultures, DADLE inhibited the PGE1-induced accumulation of cyclic AMP, however, with a less prominent effect in the brain stem cultures. Morphine did not influence the basal or the PGE1-stimulated intracellular accumulation of cyclic AMP in the cultures used and DADLE was less effective in inhibiting the PGE1-induced accumulation of cyclic AMP in the astroglial cultures, than in the neuronal enriched cultures, indicating less developed delta-receptor-second messenger efficacy in the astroglial cultures, than in the neuronal cultures. These results thus suggest the presence of delta-receptors on astroglial cells in culture, while no mu-receptors with cyclic AMP as second messenger were identified.